000 03899nam a22003735i 4500
001 282542
003 MX-SnUAN
005 20160429154155.0
007 cr nn 008mamaa
008 150903s2007 ne | o |||| 0|eng d
020 _a9781402059551
_99781402059551
024 7 _a10.1007/1402059558
_2doi
035 _avtls000335414
039 9 _a201509030202
_bVLOAD
_c201404120937
_dVLOAD
_c201404090715
_dVLOAD
_y201402041300
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aQH506
100 1 _aDeindl, Elisabeth.
_eeditor.
_9309362
245 1 0 _aTherapeutic Neovascularization–Quo Vadis? /
_cedited by Elisabeth Deindl, Christian Kupatt.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2007.
300 _ax, 262 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aClinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease -- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis -- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction -- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword -- Pampering and Priming the Heart -- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization -- Integrative Pro-angiogenic Activation: HIF-? -- The Maturation of Vessels – A Limitation to Forced Neovascularization? -- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads -- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis -- The Biology of Embryonic and Adult Endothelial Progenitor Cells -- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin -- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.
520 _aThe volume "Therapeutic Neovascularization: Quo Vadis?" picks up the current refinements in fundamental concept of neovascularization, which in the future might pave the way towards a new era of therapeutic applications. It meets an at times urgent need for treatment of patients who otherwise are not suitable for the established routines of percutaneous and surgical revascularization. At present most of the clinical trials initiated to promote neovascularization of ischemic myocardial or peripheral muscle tissue have failed to provide significant improvement of prespecified endpoints. This collection of manuscripts is selected to provide the most recent developments improving the auspices of successful revascularization therapy. Therefore, it covers sections such as the clinical challenge, novel mechanical and molecular concepts and cell therapy as an option, each composed of chapters written by experts in their fields. This collection of current and future concepts of neovascularization offers fascinating insights into refining a powerful therapeutic tool which has not yet had the chance to live up to the expectations and needs of the medical community. Indeed, the scientific modifications of a fundamentally sound concept will enable its applicability in the not so distant future. The condensed collection of current views on neovascularization is intended to speed up this process.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aKupatt, Christian.
_eeditor.
_9309363
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781402059544
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/1-4020-5955-8
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c282542
_d282542